Field

Field. The development of rice bran derived products as described in the Project Plan, the subsequent development, modification and improvement of such products as permitted herein, and the proposed business development uses for the Foreground Technology with respect to applications for rice bran protein and rice bran fiber.

Field. All prophylactic or therapeutic uses of finished Licensed Product for veterinary use only. For the avoidance of doubt, the Field shall not include use of the Licensed Product in humans

Field. Means all therapeutic, diagnostic, prophylactic and palliative uses in mammals (including humans).

Field. All use in humans of cable or plate-based products involving the sternum or anterior ribs

Field. Any and all therapeutic uses in humans, with the exceptions of the following ***

Field. All human use in any therapeutic and prophylactic indications.

Field. Means the treatment of Duchenne Muscular Dystrophy.

Field. Means the Licensed Field as such term is defined in the License Agreement.

Field. The term 'Field' shall mean the prevention, treatment or amelioration of a specific disease, symptom, state of health, or medical- or health-related condition in humans and/or animals utilizing Nicotinamide Riboside or any NAD+ precursors limited to the patent in Exhibit B for the treat of breast cancer.

Field. The THERAPEUTIC FIELD OF USE, the THERANOSTIC FIELD OF USE, or the INTERNAL RESEARCH FIELD OF USE, where such FIELDS are further defined as: A. "THERAPEUTIC FIELD" means the use of genetically modified prokaryotic organisms to treat and/or prevent disease, disorders and/or conditions by: (1) in vivo delivery of such prokaryotic organisms to a subject; or (2) treatment of a subject's sample by ex vivo contact with such genetically modified prokaryotic organisms coupled with a subsequent in vivo... delivery to said subject of at least a portion of the treated sample or by-product thereof, and for the avoidance of any doubt expressly excludes: (a) the use of such genetically modified prokaryotic organisms to manufacture biologic agents (e.g., peptide, protein, antibody or nucleic acid) for commercialization; (b) any manufacture (including making, having made, using selling, offering for sale or importing) of diagnostic products using genetically modified prokaryotic organisms; (c) any exclusive right to conduct research and/or development; and (d) any right to exclude others from the manufacture (make and have made), use, sale, offer for sale or importation of RESEARCH TOOLS. For the avoidance of doubt, this Section 1.5(A)(d) shall not limit COMPANY's ability to exclusively practice the PATENT RIGHTS in the FIELDS licensed hereunder. B. "THERANOSTIC FIELD" means the use of a LICENSED PRODUCT to sense or report how a THERAPEUTIC LICENSED PRODUCT affects the in vivo environment and/or disease condition. For the avoidance of doubt, the THERANOSTIC FIELD expressly excludes the use of a LICENSED PRODUCT to (1) diagnose a disease or condition or (2) predict the course of a disease or condition which is not being treated by a THERAPEUTIC LICENSED PRODUCT. C. "INTERNAL RESEARCH FIELD" means the practice of the PATENT RIGHTS or use of a RESEARCH TOOL for COMPANY's internal research and development. View More